EGFR and adenocarcinoma: EGFR mutations can indeed occur in adenosquamous carcinomas and in a minority of pure squamous cell carcinoma patients,36 although their response to tyrosine kinase inhibitors (TKIs) is typically shorter compared to adenocarcinoma patients.37